Combined ratio performance (loss ratio plus expense ratio) - target sub-95% for profitability
Medical malpractice premium rate changes and renewal retention rates in key states (Florida, Texas, Pennsylvania)
Prior year reserve development (favorable or adverse) impacting reported earnings
Investment portfolio yield and duration positioning relative to interest rate movements
low - Medical professional liability insurance is non-discretionary for practicing physicians due to state licensing requirements and hospital credentialing mandates, making demand highly inelastic to economic cycles. Workers' compensation premiums correlate moderately with employment levels and payroll, providing some cyclical exposure. Overall revenue is relatively recession-resistant, though investment income fluctuates with market conditions. Claims severity can increase during economic stress if juries award larger settlements.
Rising interest rates are highly positive for ProAssurance's business model. The company holds $3.5-4.0B in fixed income investments with estimated duration of 4-5 years, generating reinvestment opportunities at higher yields as bonds mature. A 100bp rate increase could add $35-40M annually to investment income over 3-4 years. Higher rates also increase discount rates applied to long-tail loss reserves, potentially releasing capital. However, rising rates compress book value multiples for insurance stocks and create mark-to-market losses on existing bond holdings (though held-to-maturity accounting mitigates P&L impact). Net effect is fundamentally positive but valuation-negative in rising rate environments.
Physician supply dynamics and shift toward employed physician models reducing individual policy demand as hospital systems self-insure or use captive structures
Telemedicine expansion and AI-assisted diagnostics potentially altering malpractice risk profiles and claims patterns in unpredictable ways
State-level tort reform erosion or plaintiff-friendly legal precedents increasing loss severity in key markets
value - The stock trades at 1.0x book value and 1.1x sales with 2.7% ROE, attracting value investors seeking turnaround stories in specialty insurance. The 67% one-year return suggests momentum investors have participated in the profitability recovery, but low single-digit ROE and minimal growth limit appeal to growth-oriented funds. Modest dividend yield (estimated 2-3%) provides some income component. The institutional investor base likely includes insurance-specialist funds and deep-value managers willing to underwrite underwriting improvement thesis.
No analyst coverage available for this stock.
2 signals unavailable — limited data for this stock
Trend
+0.6% vs SMA 50 · +2.5% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
PRA News
Unable to load news
About
providing a spectrum of healthcare liability and other insurance solutions … and more proassurance’s group of insurance companies specializes in providing the full spectrum of healthcare liability, workers’ compensation, and legal professional liability insurance options. proassurance professionals possess deep knowledge of underwriting, risk management, and claims handling, all while representing a unique pledge to treat clients and all involved fairly. healthcare liability solutions, from the simple to the most sophisticated, are available for every niche in healthcare. so whether you represent a health system, hospital, physicians, clinic, ancillary care providers and facilities, or medical technology and life sciences, we can help. of its insurance companies, proassurance group holds a financial strength rating of a+ (superior) from a.m. best; that group is made of up proassurance casualty company, proassurance indemnity company, inc., proassurance specialty insurance company, and
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
PRA◀ | $24.66 | -0.16% | $1.3B | 24.9 | -267.4% | 463.7% | 1500 |
| $312.47 | -0.24% | $842.7B | 14.8 | +330.7% | 2039.3% | 1502 | |
| $328.03 | -0.55% | $628.8B | 28.2 | +1134.0% | 5014.5% | 1498 | |
| $495.46 | -1.48% | $438.6B | 28.4 | +1641.6% | 4564.7% | 1488 | |
| $53.24 | -0.41% | $382.1B | 12.2 | -45.1% | 1592.6% | 1501 | |
| $190.18 | -0.22% | $302.0B | 16.4 | +1147.7% | 1466.4% | 1516 | |
| $923.71 | -0.01% | $274.1B | 15.5 | -138.4% | 1373.0% | 1515 | |
| Sector avg | — | -0.44% | — | 20.1 | +543.3% | 2359.2% | 1503 |